{
    "2020-02-03": [
        [
            {
                "time": "2018-02-07",
                "original_text": "Is a Disappointment in Store for Glaxo's (GSK) Q4 Earnings?",
                "features": {
                    "keywords": [
                        "Disappointment",
                        "Q4 Earnings",
                        "Glaxo",
                        "GSK"
                    ],
                    "sentiment_score": -0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-02-07",
                "original_text": "The Zacks Analyst Blog Highlights: Microsoft, Facebook, Novartis, Tesla and Raytheon",
                "features": {
                    "keywords": [
                        "Zacks Analyst Blog",
                        "Microsoft",
                        "Facebook",
                        "Novartis",
                        "Tesla",
                        "Raytheon"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "pharmaceuticals",
                        "automotive",
                        "defense"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}